BackFidelity Select Health Care Portfolio Overview

Fidelity Select Health Care Portfolio Total Revenue

Fidelity Select Health Care Portfolio's total revenue is $9.9M, below the sector sector average of $1.3B.

Get informed when a big investor buys or sells

+ Follow

Quarterly Revenue

$2.49M
2.77% YoY

As of Sep 2023

Annual Revenue (TTM)

$9.88M
6.63% YoY

Trailing 12 months ending Sep 2023

Average Revenue (Comparison Companies)

Loading

Total Revenue History

Loading

Total Revenue Comparison

Loading

Annual Revenue Growth Rate (%)

Loading

Annual Revenue Growth (Absolute)

Loading

Fidelity Select Health Care Portfolio (FSPHX) FAQ

The latest total revenue for FSPHX is $9.9M as of September 2023. That compares with $9.3M in the prior-year period — up 6.6% year over year. That is below the sector sector average of $1.3B. Investors often review this figure alongside Fidelity Select Health Care Portfolio's historical trend and sector peers before judging valuation or financial health.

Over the past year, FSPHX's total revenue moved from $9.3M to $9.9M — a 6.6% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Fidelity Select Health Care Portfolio's operating scale or balance-sheet position.

Against its sector companies, FSPHX currently prints $9.9M for total revenue, while the sector average sits near $1.3B. That is roughly 99.3% below the sector mean. Large gaps often invite a closer look at Fidelity Select Health Care Portfolio's growth, margins, and balance sheet.

A total revenue figure of $9.9M for FSPHX is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. The sector average is about $1.3B. Explore the charts below for those layers of context.

After noting FSPHX's total revenue ($9.9M), review year-over-year change from $9.3M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.